Showing results (701-710 of 728) with videos related to

Sort By:
Pageof 73
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|March 5, 2009
Echocardiography-guided interventionsFrank E Silvestry, Richard E Kerber, Michael M Brook, et al.
Journal of Cardiovascular Electrophysiology|October 22, 2016
Effect of Ventricular Arrhythmia Ablation in Patients With Heart Mate II Left Ventricular Assist Devices: An Evaluation of Ablation TherapyDavid Snipelisky, Yogesh N V Reddy, Kevin Manocha, et al.
Molecular Psychiatry|February 13, 2008
Evidence for HTR1A and LHPP as interacting genetic risk factors in major depressionC D Neff, V Abkevich, J C L Packer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 17, 2021
Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillationMalte Kuniss, Nikola Pavlovic, Vedran Velagic, et al.
Circulation|June 21, 2022
Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical TrialDerek S Chew, Yanhong Li, Patricia A Cowper, et al.
Circulation|November 15, 1996
Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic InvestigatorsG H Bardy, F E Marchlinski, A D Sharma, et al.
American Heart Journal|September 11, 2021
Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptomsNikola Pavlovic, Gian-Battista Chierchia, Vedran Velagic, et al.
Heart Rhythm|May 21, 2023
Influence of monitoring and atrial arrhythmia burden on quality of life and health care utilization in patients undergoing pulsed field ablation: A secondary analysis of the PULSED AF trialAtul Verma, David E Haines, Lucas V Boersma, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|September 5, 2008
Prognostic importance of defibrillator shocks in patients with heart failureJeanne E Poole, George W Johnson, Anne S Hellkamp, et al.
Pageof 73